Among the 108 osteosarcomas, 5% exhibited amplification of CDK4, but not MDM2, and 3% displayed amplification of both CDK4 and MDM2. In total, we included 33 samples from 25 osteosarcomas in the present study (Supplementary Table 1). The gene discussed is CDK4; the disease is osteosarcoma.